MY190213A - Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues - Google Patents

Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues

Info

Publication number
MY190213A
MY190213A MYPI2017001925A MYPI2017001925A MY190213A MY 190213 A MY190213 A MY 190213A MY PI2017001925 A MYPI2017001925 A MY PI2017001925A MY PI2017001925 A MYPI2017001925 A MY PI2017001925A MY 190213 A MY190213 A MY 190213A
Authority
MY
Malaysia
Prior art keywords
organs
tissues
cells
gene transfer
methods
Prior art date
Application number
MYPI2017001925A
Inventor
Katherine A High
Xavier Anguela
Original Assignee
Childrens Hospital Philadelphia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Philadelphia filed Critical Childrens Hospital Philadelphia
Priority claimed from PCT/US2016/039075 external-priority patent/WO2016210170A1/en
Publication of MY190213A publication Critical patent/MY190213A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to modified Factor IX coding sequence, expression cassette, vectors such as viral (e.g., lenti- or adeno-associated viral) vectors, and gene transfer methods and uses. In particular, to target Factor IX nucleic acid to cells, tissues or organs for expression (transcription) of Factor IX. Figure 19
MYPI2017001925A 2015-06-23 2016-06-23 Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues MY190213A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562183599P 2015-06-23 2015-06-23
PCT/US2016/039075 WO2016210170A1 (en) 2015-06-23 2016-06-23 Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues

Publications (1)

Publication Number Publication Date
MY190213A true MY190213A (en) 2022-04-05

Family

ID=87760869

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017001925A MY190213A (en) 2015-06-23 2016-06-23 Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues

Country Status (1)

Country Link
MY (1) MY190213A (en)

Similar Documents

Publication Publication Date Title
SA517390590B1 (en) Modified Factor IX, and Compositions, Methods and Uses for Gene Transfer to Cells, Organs and Tissues
PH12020551744A1 (en) Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
MX2020004578A (en) Casz compositions and methods of use.
MX2018001617A (en) Engineered crispr-cas9 compositions and methods of use.
EP4339287A3 (en) Modified cells and methods of therapy
PH12018502645A1 (en) Optimized mini-dystrophin genes and expression cassettes and their use
GB2569733A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
EA201992001A1 (en) COMPOSITIONS AND METHODS FOR INCREASING GENE EXPRESSION
MX2023004479A (en) Multiple vector system and uses thereof.
WO2017191274A3 (en) Rna encoding a therapeutic protein
MX2022003477A (en) Taurine supplemented cell culture medium and methods of use.
EP4241784A3 (en) Artificial nucleic acid molecules for improved protein expression
MX2017014125A (en) Alpha-amylase variants and polynucleotides encoding same.
NZ742040A (en) Engineered nucleic-acid targeting nucleic acids
MX367100B (en) Aav vector compositions and methods for gene transfer to cells, organs and tissues.
WO2015168547A3 (en) In vivo gene engineering with adenoviral vectors
CA3057899A1 (en) Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
MX2021010668A (en) Cytokine fusion proteins.
EP3964575A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX2021013913A (en) Compositions and methods for the treatment of atpase-mediated diseases.
SA521422323B1 (en) Hybrid Promoters and Their Uses in Therapy, Notably for Treating Type II Collagenopathies
WO2017041063A3 (en) Compositions and methods for identifying genetic predisposition to obesity and for enhancing adipogenesis
EP3799878A3 (en) Repeat variable diresidues for targeting nucleotides
MY190213A (en) Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues